Merck (MRK) Sale and Maturity of Investments (2009 - 2026)
Merck's Sale and Maturity of Investments - Total was $1.3 billion in Q2 2026, up 116.8% from $601 million a year earlier.
Powered by 
Analysis
Merck (MRK) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Merck's Sale and Maturity of Investments - Total was $1.92 billion through Jun 30, 2026, up 72.7% year-over-year; for FY2025, it came in at $1.68 billion, up 345.1% from FY2024.
- Sale and Maturity of Investments - Total shows a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
- In earlier years, Sale and Maturity of Investments - Total was $377 million in FY2024 (-86.6%), $2.8 billion in FY2023 (+288.8%), $721 million in FY2022 (-29.7%) and $1.03 billion in FY2021 (-63.5%).
- The Q2 2026 figure marks the highest quarterly Sale and Maturity of Investments - Total since Q4 2023.
- Compared with a year earlier, Sale and Maturity of Investments - Total was higher in four of the last six quarters, with growth averaging 243.1%.
- The best year-over-year quarter for Sale and Maturity of Investments - Total over five years was Q2 2025 (growth of 901.7%); the worst was Q1 2022 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 405.00 Mn |
| Jun 30, 2026 | 1.30 Bn |
| Dec 31, 2025 | 46.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Jun 30, 2025 | 601.00 Mn |
| Mar 31, 2025 | 456.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 60.00 Mn |
| Mar 31, 2024 | 260.00 Mn |
| Dec 31, 2023 | 1.31 Bn |
| Sep 30, 2023 | 704.00 Mn |
| Jun 30, 2023 | 285.00 Mn |
| Mar 31, 2023 | 500.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Sep 30, 2022 | 335.00 Mn |
| Jun 30, 2022 | 373.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 529.00 Mn |
| Sep 30, 2021 | 111.00 Mn |
API Access
Merck Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();